Market Place
Sourcing Support
Expert Take on CEP 2.0: A New Era of Transparency in Pharmaceutical Regulation
At the recent EDQM conference “Certified for Success: Using the CEP Procedure to Elevate Quality and Drive Trust,” ...
“Polpharma has invested over €35 million in a new facility to handle HPAPIs”
Over the recent years, the market for contract development and manufacturing organizations (CDMOs) has been growing at a fast c...
“Polpharma has the best equipment and team to deliver impurity-free products”
N-nitrosamine impurities have been in the news for some years now. SpeakPharma interviewed Karina Boszko, Head of API Regulator...
“Polpharma API’s ability to control particle size distribution resolves multiple formulation challenges for our clients”
This week, SpeakPharma interviews three experts from Poland’s leading pharmaceutical company, Polpharma. Dorota Pogoda, M...
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.